Phase II study of amsacrine in metastatic renal cell carcinoma: a Cancer and Leukemia Group B study
Related Experiment Videos
Cancer Treatment Reports
|November 1, 1983
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Nb K-edge x-ray absorption investigation of the pressure induced amorphization in A-site deficient double perovskite La1/3NbO3.
Journal of physics. Condensed matter : an Institute of Physics journal·2016
X-ray microdiffraction, TEM characterization and texture analysis of human dentin and enamel.
Journal of microscopy·2013
Elastic anomalies associated with transformation sequences in perovskites: II. The strontium zirconate-titanate Sr(Zr,Ti)O(3) solid solution series.
Journal of physics. Condensed matter : an Institute of Physics journal·2011
Effect of structure and thermodynamic stability on the response of lanthanide stannate pyrochlores to ion beam irradiation.
The journal of physical chemistry. B·2006
The distribution of structural neuropathology in pre-clinical Huntington's disease.
Brain : a journal of neurology·2002
Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.
Cancer treatment reports·1987
IV melphalan in children.
Cancer treatment reports·1987
Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.
Cancer treatment reports·1987
Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
Cancer treatment reports·1987
Doxorubicin distribution in human breast cancer.
Cancer treatment reports·1987
Phase I study of echinomycin.
Cancer treatment reports·1987
Analgesic effect of full-spectrum cannabidiol oil in burning mouth syndrome: randomized single-blind placebo trial.
Oral surgery, oral medicine, oral pathology and oral radiology·2026
Effects of a Benzimidazolium Salt on Colorectal Cancer Cells: Involvement of Apoptosis and Autophagy.
Molecules (Basel, Switzerland)·2026
Mechanistic Profiling of Phenethyl Isothiocyanate in CCRF-CEM Acute Lymphoblastic Leukemia Cells.
Pharmaceuticals (Basel, Switzerland)·2026